Greetings

President　NAKAMURA Yusuke

By walking alongside patients to strengthen collaborating among industry, government, and academia, 
we aim to accelerate research that contributes to society.

The National Institutes of Biomedical Innovation, Health and Nutrition (NIBN) has been actively engaged in research and development, aiming to transform incurable diseases into curable ones and to realize a society where people live long and  healthy lives.

In 2025, the post-war baby boomer generation has reached the advanced age group, ushering in a super-aged society. As a result, the importance of living long and healthy lives has become increasingly significant. Amid this, our second 7-years med- to long-term plan started in 2022, tackling various challenges in anticipation of the "era of 100-year lifespans". Maintaining and improving health through diet and exercise also requires approaches tailored to each individual. Furthermore, in the event of illness, selecting and providing optimal medical care personalized to each person will be essential in the coming era. We aim to further advance drug discovery and nutritional science by leveraging cutting-edge AI analysis and generative AI technologies, ultimately contributing to society.

In recent years, we have been building a platform that supports drug discovery by comprehensively collaborating with the Osaka International Cancer Institute, while also utilizing generative AI to reduce the burden on healthcare professionals and enable real-time, real-world medical data collection and database development. Building on these foundations, we are working together as one with patients and medical institutions to transform diseases that are currently incurable into ones that can be treated.

As a national research institute guided by the three key domains of biomedical innovation, health, and nutrition, we are committed to addressing challenging areas such as intractable and rare diseases, where private enterprises may struggle to engage. Furthermore, to fully leverage the complementary strengths of the two institutes – from health maintenance to pharmaceutical development – we are placing greater emphasis on the integrated fields that bridge medicine with health and nutrition. In the interdisciplinary domain, we are exploring new possibilities, including research on nutrition, gut microbiota, and immune-related functions. 

Moving forward, we will continue our dedicated efforts to develop foundational technologies for innovative drug discovery and to conduct research on food, nutrition, and exercise. Through these initiatives, we aspire to contribute to extending healthy lifespans and strive to become a leading research institute at the forefront of a vibrant and thriving Japan. To bring hope to patients and to Japan as a whole, we would greatly appreciate your continued - and even greater - support and cooperation.

National Institute of Biomedical Innovation Director, Research Institute KATAGIRI Toyomasa  / National Institute of Health and Nutrition Director, Research Institute TAKIMOTO Hidemi